Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

FDA grants orphan drug designation to elamipretide for LHON

europeanpharmaceuticalreviewMay 02, 2018

Tag: FDA , Orphan Drug , LHON , elamipretide

PharmaSources Customer Service